Data from The Cancer Genome Atlas Prostate Adenocarcinoma (TCGA PRAD) cohort showed that GSTP1 was methylated in >85% of tumour samples, with concomitant suppression of GSTP1 mRNA expression.12 The gene discussed is GSTP1; the disease is prostate adenocarcinoma.